Dr. Rogers's group uses genetics and genomics methodologies to identify novel ARDS pathobiology; they hope that this will enable identification of novel biomarkers, phenotypes, and treatments for the disease.

Dr. Andrew J. Mannix is an assistant professor of Materials Science and Engineering at Stanford University. He completed his B.S. in Materials Science and Engineering at the University of Illinois at Urbana-Champaign, and his Ph.D. in Materials Science and Engineering at Northwestern University as an NSF GRFP Fellow, where he worked on the growth and atomic-scale characterization of new 2D materials.

Dr. Gentles's lab is interested in computational systems biology, primarily in cancer. They develop and apply methods to understand biological processes underlying disease, using high-throughput genomic and proteomic datasets and integrating them with phenotypes and clinical outcomes.

The Huberman lab is focused on brain function, development and repair with emphasis on regeneration to prevent and cure blindness.